Podcast – June/July 2022 Monthly Round Up
Iain and Simon run through the best of the blog from June and July 2022.
Podcast – June/July 2022 Monthly Round Up Read More
dom9
Baricitinib for hospitalised COVID19 patients. St Emlyn’s
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More
The EXIT study extrication consensus statements. St Emlyn’s
As several of you may know already, I’ve been spending a lot more time in the pre-hospital environment in the last few years. Despite many years working in busy emergency
The EXIT study extrication consensus statements. St Emlyn’s Read More
The FORCE study: St Emlyn’s
As someone who works across both PEM and adult EM it’s interesting to reflect on how the workload varies. These days my adult work is heavily skewed to complex majors
The FORCE study: St Emlyn’s Read More
JC: Vitamin C and sepsis (again). St Emlyn’s
The story of vitamin C in sepsis is fascinating. There was a great deal of controversy around what became known as the Marik protocol (after Prof. Paul Marik). The protocol
JC: Vitamin C and sepsis (again). St Emlyn’s Read More
Differential prescribing of TXA by gender. St Emlyn’s
Tranexamic acid in trauma is a well-established standard of care in most mature trauma systems. The two major trials of TXA, CRASH 2 and 3 suggest a small but important
Differential prescribing of TXA by gender. St Emlyn’s Read More
How to become a sub-specialist in emergency care research. St Emlyn’s
At a basic level emergency care clinicians should be trained in Good Clinical Practice and able to recruit to trials. However some will want to make research into a larger
How to become a sub-specialist in emergency care research. St Emlyn’s Read More
The RePHILL trial
This week we see the publication of the RePHILL trial. This is something we have been looking forward to for some time. A randomised controlled trial of the use of